Blog: Blog2

GPCR News

May 31, 20221 min read

Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...

June 2022 Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital Adrenal Hyperplasia at ENDO...

Jan 1, 20221 min read

Learn more about Neurocrine Biosciences with their new video

January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...

Dec 31, 20211 min read

Learn more about Neurocrine Biosciences with their new video

January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...

Dec 1, 20211 min read

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

December 2021 "Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today announces...

Nov 30, 20211 min read

Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...

December 2021 Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated...

Oct 31, 20211 min read

California gold rush for Sosei Heptares

November 2021 "Cambridge’s Japanese-owned life sciences company Sosei Heptares has clinched a lucrative deal with California-based...